Living at high altitudes could reduce risk of common disease, study suggests

Living at high altitudes may lower the risk of diabetes, and scientists believe they have finally figured out why.

A new study from the Gladstone Institutes in San Francisco examined how red blood cells behave in low-oxygen environments. The findings, published in the journal Cell Metabolism, reveal that at high elevations, red blood cells begin absorbing large amounts of glucose from the bloodstream, acting as a "sponge" for sugar.

When oxygen levels drop, these cells then alter their metabolism to deliver oxygen more efficiently. 

DIABETES PATIENTS EXPERIENCE LOWER DEATH RATE WITH COMMON MEDICATION

This shift also lowers circulating blood sugar, which researchers say explains the lower diabetes risk seen in mountain-dwelling populations.

A previous study of over 285,000 adults in the United States found that people living at high altitudes (1,500-3,500 meters) were significantly less likely to have diabetes than those living at sea level, even after adjusting for factors like diet, age and ethnicity.

"Red blood cells represent a hidden compartment of glucose metabolism that has not been appreciated until now," said senior author Isha Jain, a Gladstone investigator and professor of biochemistry at UC San Francisco, in the press release. "This discovery could open up entirely new ways to think about controlling blood sugar."

Previously, Jain’s team conducted experiments on mice to better understand hypoxia, or reduced oxygen levels in the blood.

WHAT YOUR BUTT SHAPE COULD REVEAL ABOUT YOUR HEALTH, ACCORDING TO SCIENTISTS

Mice exposed to thin air cleared sugar from their bloodstream almost instantly after eating, a trait typically linked to a lower risk of diabetes. Initially, however, researchers couldn't figure out where the sugar was going.

"We looked at muscle, brain, liver — all the usual suspects — but nothing in these organs could explain what was happening," said Yolanda Martí-Mateos, a postdoctoral scholar in Jain’s lab and the study’s first author.

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

The team discovered the answer using an alternative imaging method: the red blood cells themselves were the missing "glucose sink."

By using a different type of imaging, the team found that the red blood cells were holding onto the glucose.

CLICK HERE FOR MORE HEALTH STORIES

Under hypoxic conditions, the mice produced more red blood cells, and each cell absorbed significantly more glucose than they did in normal conditions.

The researchers even developed a drug, HypoxyStat, that mimics this high-altitude effect. In laboratory tests, the drug completely reversed high blood sugar in diabetic mice.

The researchers acknowledged some limitations with the study. The research focused on one specific mouse strain known for its sensitivity to blood sugar. While humans show similar results, testing other strains would confirm that the findings are universal.

To ensure consistent results, the team only studied young male mice. Because age and sex significantly impact how red blood cells are produced, more research is needed to determine whether these findings hold true for females and older populations.

TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ

"This is just the beginning," Jain said.

"There's still so much to learn about how the whole body adapts to changes in oxygen, and how we could leverage these mechanisms to treat a range of conditions."

from Health News Today on Fox News https://ift.tt/GW41wPd

Read More

5 ways to preserve your vision as you age, according to an ophthalmologist

As people age, vision naturally declines and the risk of eye conditions increases. That includes age-related macular degeneration (AMD), a condition that typically occurs in patients older than 50.

AMD is one of the leading causes of vision loss among adults over 60 and impacts millions of Americans, according to the American Macular Degeneration Foundation.

The condition degrades the ability to read, drive and recognize faces. AMD has no cure, so experts advocate for early detection and prevention.

DOCTOR WARNS OF 2 SIMPLE FOOD MISTAKES THAT INCREASE CHRONIC DISEASE RISK

In more advanced stages of AMD, patients may notice wavy straight lines, dark spots in their vision, or blurred central vision, according to ophthalmologist Dr. Vaidehi Dedania at NYU Langone Health.

Vision loss can be particularly difficult for seniors, as impaired eyesight can lead to more falls, decreased mobility and loss of independence, the doctor told Fox News Digital.

"We are moving toward a world where we don't just react to vision loss — we can intercept it and take measures to delay what used to be inevitable for many patients," Dedania said.

While the main risk factors for age-related macular degeneration are genetics and aging, the expert shared the following five lifestyle changes that could decrease the risk and severity of the disease.

DOCTOR SHARES 3 SIMPLE CHANGES TO STAY HEALTHY AND INDEPENDENT AS YOU AGE

Smoking is a major risk factor of AMD and can "significantly impact" the risk of vision loss, according to Dedania.

"The oxidative stress from smoking can really affect the retinal cells, and this is what increases someone's risk of macular deterioration," she told Fox News Digital. The habit can also speed up AMD's progression and reduce the effectiveness of treatments.

"We really encourage people who smoke to stop smoking, especially if they have family members with this condition," the expert told Fox News Digital. 

People who stopped smoking 20 years ago may have a risk level similar to those whose risk is based primarily on age and genetics, she noted. "That’s why quitting as early as possible is so important."

Eating a healthy diet can impact the advancement of any disease, including AMD.

Diets high in processed foods, sugar and fat are associated with macular degeneration due to an imbalance of the gut microbiome, according to a recent study by researchers at the University of California, Davis.

COMMON DIABETES DRUG MAY HELP PRESERVE EYESIGHT AS PEOPLE AGE

"These are things that are currently still being explored, but we definitely know that our diet affects our risk of macular degeneration and how advanced it's going to be," Dedania told Fox News Digital.

She recommends adding more leafy greens and maintaining a balanced diet to support a healthy gut microbiome. In particular, she is a big advocate of the Mediterranean diet.

Certain supplements can decrease the risk of AMD. In particular, AREDS2 is a specific combination of vitamins and minerals used in the Age-Related Eye Disease Study 2.

In clinical trials, the AREDS2 formula was shown to help slow progression of AMD in people with intermediate or late stages of the disease, according to the National Eye Institute.

"While patients can take these supplements early on, we really only have data to show that it helps after they've already reached the intermediate stage," Dedania noted.

While taking the supplement very early on may not significantly impact risk, it is safe to start anytime as long as patients aren't doubling up on their vitamins, according to the doctor.

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

Dedania noted that earlier formulations of AREDS — without the "2" — included beta-carotene, which has since been removed due to its link to lung cancer in smokers.

"Make sure that you're finding the supplement that has AREDS2 on it and use that one," she advised.

Regular movement is another core pillar of health that can help slow the progression of disease.

"Exercise falls into the overall balance of a healthy lifestyle," Dedania said.

CLICK HERE FOR MORE HEALTH STORIES

"We know that exercise also diminishes oxidative stress, and these are things that we aim to do just for overall well-being — but there are studies that show that it also benefits patients with macular degeneration in terms of their risk of advanced disease."

Seeing your eye doctor for routine screenings could be the key to spotting an issue before it’s too late.

With AMD, patients are not typically symptomatic until they’ve reached intermediate or advanced stages of the disease. "Patients may have macular degeneration and they don't know," Dedania said.

The ophthalmologist reiterated that the disease is not frequently seen in patients under 50, and signs often go undetected in patients over 60.

TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ

"It is important for patients 50 and above to have a general eye exam and come equipped with the knowledge of whether they have family members with macular degeneration," she advised.

from Health News Today on Fox News https://ift.tt/a3WhIJn

Read More

Alzheimer's symptoms could be predicted years in advance through one simple test

A simple blood test could predict not only a person’s risk of developing Alzheimer’s disease, but also the year symptoms will begin.

Researchers at the Washington University School of Medicine in St. Louis set out to determine if levels of a specific protein in the blood could be used as a "biological clock" to predict when signs of the disease will emerge.

The specific protein, known as p-tau217, forms "tangles" in the brain that disrupt communication between nerve cells. In a healthy brain, tau helps to stabilize the structure of nerve cells.

HIDDEN BRAIN CONDITION MAY QUADRUPLE DEMENTIA RISK IN OLDER ADULTS, STUDY SUGGESTS

In some cases, brain scans can be used to detect these tangles when diagnosing Alzheimer’s. Preliminary studies have suggested that the same method could be used to determine a progression timeline.

As these imaging tests are often complex and expensive, the research team wanted to explore whether a blood test could monitor the same proteins and produce similar results.

The study, published in the journal Nature Medicine, analyzed data from more than 600 older adults enrolled in two long-term Alzheimer’s research projects.

ALZHEIMER’S RISK TIED TO HOW THE BODY HANDLES SUGAR AFTER EATING, STUDY FINDS

By comparing blood samples with participants’ cognitive performance over several years, the team found that p-tau217 levels rise in a "remarkably consistent" pattern long before memory loss begins, according to a press release.

The team then created a model that uses a patient's age and protein levels to estimate when symptoms will appear, with a margin of error of three to four years.

"We show that a single blood test measuring p-tau217 can provide a rough estimate of when an individual is likely to develop symptoms of Alzheimer’s disease," lead author Kellen K. Petersen, PhD, instructor of neurology at Washington University in St. Louis, told Fox News Digital.

The researchers found that older adults developed symptoms much more rapidly after p-tau217 became abnormal, he noted.

LOWER DEMENTIA RISK LINKED TO ROUTINE VACCINATION IN MAJOR NEW ANALYSIS

"For example, people who first had abnormal p-tau217 levels around age 60 didn’t develop Alzheimer’s symptoms for about 20 years, whereas those who first had abnormal p-tau217 levels around age 80 developed symptoms after only about 10 years," Petersen said. 

This suggests that age and disease-related changes in the brain can influence how quickly Alzheimer’s symptoms become apparent, the researcher concluded.

"This could transform how researchers design clinical trials and, eventually, how clinicians identify people at highest risk for cognitive decline associated with Alzheimer’s years before decline begins," Chicago-based Rebecca M. Edelmayer, PhD, vice president of scientific engagement at the Alzheimer’s Association, told Fox News Digital.

"A blood test is generally much less expensive and easier to administer than a brain scan or spinal‑fluid test. In the future, it could help doctors and researchers identify people who may benefit from early treatments," added Edelmayer, who was not involved in the study.

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

The study did have some limitations and caveats.

"We were only able to make predictions for individuals whose p-tau217 levels fell within a certain range, although it was a fairly wide range," Petersen shared. "The models were developed in relatively healthy and well-educated research cohorts that were not diverse, so the results may not apply well to the broader population."

While the researchers referenced in-home blood tests in this study, they cautioned against people seeking out and taking these tests themselves.

CLICK HERE FOR MORE HEALTH STORIES

"At this point, we do not recommend that any cognitively unimpaired individuals have any Alzheimer’s disease biomarker test," Dr. Suzanne Schindler, a neurologist at Washington University who was a co-author of the study, said in the press release.

Peterson acknowledged that these results are still experimental and ripe for improvement.

"The current estimate is not yet accurate enough for clinical use or personal medical decision-making, but we expect that it will be possible to create more accurate models," he told Fox News Digital.

Looking ahead, the team hopes to refine the test by researching other Alzheimer’s-linked proteins to narrow the margin of error, Schindler said. More diverse participants are also needed to confirm the results.

Two large clinical trials are now in progress, aiming to determine whether people with high levels of this protein can benefit from treatment with one of two Alzheimer’s drugs before symptoms appear.

Lecanemab and donanemab are the only approved drugs designed to reduce levels of plaques in the brain associated with Alzheimer’s disease. Researchers hope that treating people earlier may boost the drugs’ effectiveness.

TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ

"There are many other blood and imaging biomarkers, as well as cognitive tests, that we can combine with plasma p-tau217 to improve the accuracy of predicting symptom onset," Petersen said. "We hope this work will lead to even better models that will be useful to individuals."

from Health News Today on Fox News https://ift.tt/yDKe5EI

Read More

Heavy snow is recipe for serious heart attack risk, experts say: What to know

In addition to travel and logistical challenges, heavy snowfall  can be detrimental to people's health.

As the northeast faces historic snow accumulation this week, experts are warning of the physical risks of shoveling heavy snow, particularly for those who do not exercise regularly or have pre-existing health conditions.

"The combination of the wet, heavy snow and the heavy winds make it more of a health risk because it’s much harder to get around," Fox News senior medical analyst Dr. Marc Siegel told Fox News Digital.

SHOVELING SNOW COULD POSE DANGEROUS HEALTH RISK FOR ONE GROUP

"In the aftermath of the storm, as the temperatures drop, the heavy, wet snow forms ice, which makes walking and driving treacherous."

Heavy, wet snow can get inside clothes and cause "more of a chill," potentially leading to hypothermia in severe cases, according to Siegel.

In a Monday appearance on "Fox & Friends," the doctor stressed the importance of being properly dressed in these conditions.

"I saw this morning people who weren't covered properly … weren't wearing gloves, didn't have the full hat, or the kind of overcoat they needed," he said.

"They also weren't looking out for each other. You need to look out for each other. With this kind of wind, you get really easily discombobulated."

Siegel urged people to stay indoors unless it’s absolutely necessary to leave their home.

"Watch out if you are outside for brief periods — for fallen power lines or for trees that are down. That's very, very dangerous as well," he cautioned. "That's where a lot of the injuries come from."

There’s also an increased risk of falling, as well as electrocution from power lines being weighed down by heavy snow. Going without power poses its own health risks, Siegel mentioned.

Dr. Joshua Latzman, cardiologist at White Plains Hospital Physician Associates in White Plains, New York, shared with the American Heart Association (AMA) that research has shown heavy snow shoveling can put "significant stress on the heart."

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

"In frigid temperatures, that added strain can increase the risk of a heart-related event," he said. "This can be especially dangerous for people who are out of shape or not used to strenuous activity."

Shoveling in the wind can also increase the risk of a health event, since exposure to colder air can raise blood pressure and constrict the coronary arteries, according to the AMA.

"Many heart-related events occur in people who are usually inactive," Latzman went on. "When someone who is sedentary suddenly takes on heavy shoveling after a storm, that unexpected strain can unfortunately lead to a serious emergency."

Straining to lift something heavy can have the same effect if normal breathing is impacted.

Other at-risk groups include people who are obese, those who smoke or have smoked in the past, people with diabetes, and those with high cholesterol or high blood pressure. Anyone who has previously had a heart attack or stroke is also at greater risk, the AMA reported.

CLICK HERE FOR MORE HEALTH STORIES

"Anyone with these characteristics, including people who have undergone bypass surgery or coronary angioplasty, should not be shoveling snow," Latzman concluded.

Siegel urged those who may be at risk to avoid going out with their shovels and "being a hero."

"It's about the most cardiac expenditure of energy that you can have," he said. "So if you've been sedentary, don't go and shovel. Get a younger person or somebody who's in much better shape to do it."

TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ

If shoveling is unavoidable, experts advise doing it gradually and at a comfortable pace. The AMA also suggests covering your mouth and nose and dressing in layers, including a hat and gloves.

Pushing or sweeping the snow is safer than lifting and throwing, as it requires less energy.

from Health News Today on Fox News https://ift.tt/Ku2mdli

Read More

Scientists discover 5,000-year-old bacterium resistant to modern antibiotics

Scientists have discovered that a bacterium trapped in an ice cave for 5,000 years is resistant to several modern antibiotics.

The bacterium was found in Scarisoara Ice Cave in Romania, where researchers drilled a 25-meter ice core representing about 13,000 years of frozen history.

The research was published in the journal Frontiers in Microbiology.

ANCIENT PLAGUE MYSTERY CRACKED AFTER DNA FOUND IN 4,000-YEAR-OLD ANIMAL REMAINS

To prevent contamination, the ice samples were carefully stored and transported to the lab while still frozen. From the ice, scientists isolated a strain of bacteria called Psychrobacter SC65A.3. 

Although it is thousands of years old, the strain was found to resist 10 antibiotics that are commonly used today to treat serious infections.

These include medications such as rifampicin, vancomycin and ciprofloxacin, the study found.

CLICK HERE TO SIGN UP FOR OUR LIFESTYLE NEWSLETTER

"The 10 antibiotics we found resistance to are widely used in oral and injectable therapies used to treat a range of serious bacterial infections in clinical practice," said Cristina Purcarea, senior scientist at the Institute of Biology Bucharest of the Romanian Academy, in a press release.

Researchers tested the ancient strain against 28 antibiotics from 10 drug classes and identified more than 100 genes linked to antibiotic resistance.

TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ

"Studying microbes such as Psychrobacter SC65A.3 retrieved from millennia-old ice cave deposits reveals how antibiotic resistance evolved naturally in the environment, long before modern antibiotics were ever used," Purcarea said.

CLICK HERE FOR MORE LIFESTYLE STORIES

The findings suggest that antibiotic resistance existed in nature long before the development of modern medicines, according to the researchers.

The strain also showed resistance to medications including trimethoprim, clindamycin and metronidazole, which are used to treat infections of the lungs, urinary tract, skin and reproductive system.

The study examined just one bacterial strain from one cave sample, and there is no evidence that the ancient microbe is currently infecting people or spreading, the researchers noted.

Experts also pointed out that Psychrobacter is an environmental bacterium that doesn't have clinical antibiotic "breakpoints," which are clear cut-off numbers that tell doctors whether a bacterium is officially "resistant" to an antibiotic.

Because this environmental bacterium doesn’t have established clinical testing standards, its lab-measured resistance can’t be interpreted the same way doctors classify dangerous hospital superbugs.

from Health News Today on Fox News https://ift.tt/7BqSfFL

Read More

Blood test could predict when Alzheimer's symptoms will start years in advance

A simple blood test could predict not only a person’s risk of developing Alzheimer’s disease, but also the year symptoms will begin.

Researchers at the Washington University School of Medicine in St. Louis set out to determine if levels of a specific protein in the blood could be used as a "biological clock" to predict when signs of the disease will emerge.

The specific protein, known as p-tau217, forms "tangles" in the brain that disrupt communication between nerve cells. In a healthy brain, tau helps to stabilize the structure of nerve cells.

HIDDEN BRAIN CONDITION MAY QUADRUPLE DEMENTIA RISK IN OLDER ADULTS, STUDY SUGGESTS

In some cases, brain scans can be used to detect these tangles when diagnosing Alzheimer’s. Preliminary studies have suggested that the same method could be used to determine a progression timeline.

As these imaging tests are often complex and expensive, the research team wanted to explore whether a blood test could monitor the same proteins and produce similar results.

The study, published in the journal Nature Medicine, analyzed data from more than 600 older adults enrolled in two long-term Alzheimer’s research projects.

ALZHEIMER’S RISK TIED TO HOW THE BODY HANDLES SUGAR AFTER EATING, STUDY FINDS

By comparing blood samples with participants’ cognitive performance over several years, the team found that p-tau217 levels rise in a "remarkably consistent" pattern long before memory loss begins, according to a press release.

The team then created a model that uses a patient's age and protein levels to estimate when symptoms will appear, with a margin of error of three to four years.

"We show that a single blood test measuring p-tau217 can provide a rough estimate of when an individual is likely to develop symptoms of Alzheimer’s disease," lead author Kellen K. Petersen, PhD, instructor of neurology at Washington University in St. Louis, told Fox News Digital.

The researchers found that older adults developed symptoms much more rapidly after p-tau217 became abnormal, he noted.

LOWER DEMENTIA RISK LINKED TO ROUTINE VACCINATION IN MAJOR NEW ANALYSIS

"For example, people who first had abnormal p-tau217 levels around age 60 didn’t develop Alzheimer’s symptoms for about 20 years, whereas those who first had abnormal p-tau217 levels around age 80 developed symptoms after only about 10 years," Petersen said. 

This suggests that age and disease-related changes in the brain can influence how quickly Alzheimer’s symptoms become apparent, the researcher concluded.

"This could transform how researchers design clinical trials and, eventually, how clinicians identify people at highest risk for cognitive decline associated with Alzheimer’s years before decline begins," Chicago-based Rebecca M. Edelmayer, PhD, vice president of scientific engagement at the Alzheimer’s Association, told Fox News Digital.

"A blood test is generally much less expensive and easier to administer than a brain scan or spinal‑fluid test. In the future, it could help doctors and researchers identify people who may benefit from early treatments," added Edelmayer, who was not involved in the study.

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

The study did have some limitations and caveats.

"We were only able to make predictions for individuals whose p-tau217 levels fell within a certain range, although it was a fairly wide range," Petersen shared. "The models were developed in relatively healthy and well-educated research cohorts that were not diverse, so the results may not apply well to the broader population."

While the researchers referenced in-home blood tests in this study, they cautioned against people seeking out and taking these tests themselves.

CLICK HERE FOR MORE HEALTH STORIES

"At this point, we do not recommend that any cognitively unimpaired individuals have any Alzheimer’s disease biomarker test," Dr. Suzanne Schindler, a neurologist at Washington University who was a co-author of the study, said in the press release.

Peterson acknowledged that these results are still experimental and ripe for improvement.

"The current estimate is not yet accurate enough for clinical use or personal medical decision-making, but we expect that it will be possible to create more accurate models," he told Fox News Digital.

Looking ahead, the team hopes to refine the test by researching other Alzheimer’s-linked proteins to narrow the margin of error, Schindler said. More diverse participants are also needed to confirm the results.

Two large clinical trials are now in progress, aiming to determine whether people with high levels of this protein can benefit from treatment with one of two Alzheimer’s drugs before symptoms appear.

Lecanemab and donanemab are the only approved drugs designed to reduce levels of plaques in the brain associated with Alzheimer’s disease. Researchers hope that treating people earlier may boost the drugs’ effectiveness.

TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ

"There are many other blood and imaging biomarkers, as well as cognitive tests, that we can combine with plasma p-tau217 to improve the accuracy of predicting symptom onset," Petersen said. "We hope this work will lead to even better models that will be useful to individuals."

from Health News Today on Fox News https://ift.tt/UFY6QV8

Read More

Some supplements may pose risks for people with diabetes, experts say

Some surveys find that about 75% of U.S. adults have used supplements, while federal survey data shows that 58% used one in the past 30 days — but some groups should exercise caution, experts say.

There are many different supplements — including vitamins, minerals, herbs, amino acids and probiotics — designed to fill nutrient gaps and support overall wellness. Some target specific functions, such as immune support, muscle recovery and bone health, according to multiple medical sources.

Unlike prescription drugs and over-the-counter medications, supplements usually aren’t FDA-approved before they are marketed, but the FDA does regulate them and can take action against unsafe or misbranded products.

POPULAR WEIGHT-LOSS DRUGS LINKED TO RARE 'PIRATE DISEASE,' RESEARCHERS WARN

For people with diabetes, the following supplements could pose serious health risks, as they can affect blood glucose levels or interact with medications, per the National Institutes of Health.

Dawn Menning, a California-based registered dietitian and certified diabetes care and education specialist with Nutu, a healthy lifestyle app, says people with diabetes should avoid taking St. John's Wort as a supplement. 

Primarily touted as a natural remedy for mild to moderate depression, St. John’s Wort could have additional benefits for anxiety, sleep issues, and menopausal or PMS-related symptoms.

THE ZERO-CALORIE SUGAR SUBSTITUTE YOU'RE USING MAY DO MORE THAN SWEETEN FOOD, STUDY SAYS

"This herbal remedy can interfere with many diabetes medications by affecting the way the body breaks them down," Menning told Fox News Digital. "This can make medications less effective and blood sugar management more difficult."

This supplement is often marketed for its ability to improve blood sugar regulation in people with type 2 diabetes, Menning noted, but there is limited evidence and the research is "mixed."

"Taking this supplement with insulin or oral diabetes medications may increase the risk of hypoglycemia," she cautioned. This condition can increase the risk of dizziness, fatigue and fainting, according to Healthline.

These are often taken to help with reducing blood sugar levels in people with diabetes, Menning noted.

GLP-1 WEIGHT-LOSS MEDICATIONS LINKED TO IMPROVED CANCER SURVIVAL IN CERTAIN PATIENTS

"It contains compounds such as polypeptide-p, which may act like insulin," she said. "Taking this with diabetes medications could increase the risk of hypoglycemia."

This supplement is sometimes used to help manage cholesterol levels — but in people with diabetes, it may also raise blood sugar levels, increasing the risk of hyperglycemia (high blood sugar).

SIMPLE DAILY HABIT COULD HELP PEOPLE WITH TYPE 2 DIABETES MANAGE BLOOD SUGAR

"I would caution against using high-dose niacin supplements because it can noticeably raise blood sugar levels and make it harder to keep A1c in an optimal range," Michelle Routhenstein, preventive cardiology dietitian at EntirelyNourished.com in New York, told Fox News Digital.

Asian ginseng has been linked to a boost in energy, focus and immune system health. It also contains antioxidants, which can provide cellular protection, according to Cleveland Clinic.

While it has also been linked to improved cardiometabolic factors for those with prediabetes and diabetes, some evidence suggests that ginseng could lower blood sugar levels when combined with diabetes medications.

This supplement is primarily used as an antioxidant and a source of vitamin A to support vision, immune function, and overall eye and skin health.

CLICK HERE FOR MORE HEALTH STORIES

"The American Diabetes Association recommends against β-carotene supplementation for people with diabetes because of its association with increased lung cancer and cardiovascular mortality risk," Jordan Hill, a registered dietitian with Top Nutrition Coaching in Colorado, told Fox News Digital. 

Cinnamon is often promoted as a supplement for diabetes management and weight loss, as some research has shown it can help to reduce blood sugar and lower insulin resistance.

However, consuming large amounts of cinnamon can enhance the effects of diabetes and cause blood sugar levels to fall too low, which can cause hypoglycemia, Healthline warns.

Cinnamon also includes a compound called coumarin, which can cause liver damage if consumed in large amounts.

This supplement can help to promote healthy digestion, skin and nervous system function, according to Mayo Clinic.

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

High doses of nicotinic acid (a form of niacin) can raise blood sugar levels and interfere with the effectiveness of diabetes medications, warns the National Institutes of Health.

"These doses can even raise blood sugar levels in people who don’t have diabetes," the NIH states.

Oral aloe vera is often promoted for diabetes, weight loss and inflammatory bowel disease.

However, when paired with diabetes medications, it could cause blood sugar levels to dip and increase the risk of hypoglycemia with medications, according to the National Institutes of Health. It can also cause gastrointestinal side effects.

For most supplements, Menning noted, "there isn't evidence to support a beneficial effect on diabetes or its complications."

The American Diabetes Standards of Care state: "Without underlying deficiency, there are no benefits from herbal or nonherbal (i.e., vitamin or mineral) supplementation for people with diabetes."

The American Association of Clinical Endocrinology advises caution with all unregulated nutritional supplements due to "inconsistent composition, quality and potential for harm," Hill said.

TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ

"The primary concern with most supplements is not direct harm, but rather the lack of regulatory oversight," he told Fox News Digital.

Experts recommend speaking with a doctor before starting any supplement to understand how it could affect blood sugar levels, medications or overall diabetes management.

from Health News Today on Fox News https://ift.tt/b3TWzwM

Read More